Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features.
| Autor: | Rebello RJ; Translational Oncogenomics Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre, Manchester, UK. Electronic address: richard.rebello@manchester.ac.uk., Bristow RG; Translational Oncogenomics Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre, Manchester, UK. Electronic address: robert.bristow@manchester.ac.uk. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2020 May; Vol. 32 (5), pp. 298-302. Date of Electronic Publication: 2020 Mar 06. |
| DOI: | 10.1016/j.clon.2019.11.002 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect